Pharmaceutical News

RSS

Researchers test NicVAX vaccine to help people quit smoking, avoid relapses

In a unique twist to a decades-old health crisis, Michigan State University researchers are testing a new vaccine to help people quit smoking and avoid relapses.

21 May 2010

Updates on Micromet's BiTE antibody development programs to be made at two medical conferences

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that updates on several of its BiTE antibody development programs will be made at two upcoming medical conferences.

21 May 2010

Dr. Reddy's Laboratories launches tacrolimus capsules in the US market

Dr. Reddy's Laboratories today announced that it has launched tacrolimus capsules, (0.5mg, 1mg, 5mg), a bioequivalent generic version of Prograf Capsules, in the US market on May 20, 2010. The United States Food & Drug Administration granted an approval of Dr. Reddy's ANDA for tacrolimus capsules on May 13, 2010.

21 May 2010

Vitacost.com announces expansion of operations in North Carolina

Vitacost.com, Inc., a leading online retailer and direct marketer of health and wellness products, today announced the groundbreaking for the expansion of its east coast manufacturing and distribution facility in Lexington, North Carolina.

21 May 2010

IGF1 drug improves nerve cell communication in PMS mouse model

Researchers from Mount Sinai School of Medicine have identified a drug that improves communication between nerve cells in a mouse model of Phelan-McDermid Syndrome (PMS).

21 May 2010

Common misconceptions about general anesthesia

Eight-five per cent of patients who took part in a survey shortly after day surgery said that they had been anxious about receiving a general anaesthetic, according to research in the May issue of the Journal of Advanced Nursing.

21 May 2010

Influenza antiviral drugs not hoarded during recent H1N1 flu season, says Prime Therapeutics

Despite concerns from public health officials, influenza antiviral drugs were not hoarded during the recent H1N1 flu season, according to a new analysis presented recently at the Academy of Managed Care Pharmacy's 22nd Annual Meeting in San Diego by Prime Therapeutics (Prime), a thought leader in pharmacy benefit management.

21 May 2010

New data highlighting Pfizer's approach to cancer drug development to be presented at ASCO meeting

Pfizer Oncology will present new data highlighting the company's focused approach to cancer drug development through the identification and validation of molecular targets. These results will be presented at the 46th Annual American Society of Clinical Oncology meeting in Chicago from June 4-8.

21 May 2010

Sorrento Therapeutics receives STTR grant to develop antibody therapeutics to combat MRSA

Sorrento Therapeutics, Inc. today announced that it has received an Advanced Technology Small Business Technology Transfer Research grant from the National Institute of Allergy and Infectious Diseases. The peer-reviewed grant was awarded to support the Company's program to generate and develop novel antibody therapeutics and vaccines to combat Staphylococcus aureus infections, including methicillin-resistant S. aureus, by disrupting quorum sensing, a bacterial communication process essential to virulence.

21 May 2010

Genentech to present new data for targeted cancer medicines at 46th ASCO

Genentech, Inc., a wholly owned member of the Roche Group, today announced that it will present new data for its targeted cancer medicines and the way they may be used in several different cancer types at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO). Approximately 400 abstracts featuring Genentech and Roche's cancer medicines and investigational agents across 30 cancer types will be presented during the meeting that is taking place June 4 to 8, 2010 in Chicago.

21 May 2010

Americans divided over nation’s drug approval process

Nearly three-quarters of Americans are confident in our system for reviewing the effectiveness and safety of new medicines and medical devices, yet 41% say it takes too long to approve a drug and allow it to be sold to consumers.

21 May 2010

VIA-2291 can reduce inflammation in patients with atherosclerosis: Study

The results of a major clinical study carried out at the Montreal Heart Institute by Dr. Jean-Claude Tardif are now available in the journal Circulation Cardiovascular Imaging. Dr. Tardif is a cardiologist and director of the MHI Research Centre, as well as a professor in the faculty of medicine and holder of the atherosclerosis research chair at the Universit- de Montr-al.

21 May 2010

Salix announces additional intellectual property protection for rifaximin in treatment of IBS

Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).

21 May 2010

Abbott to acquire Piramal's Healthcare Solutions business

Abbott announced a definitive agreement with Piramal Healthcare Limited to acquire full ownership of Piramal's Healthcare Solutions business (Domestic Formulations), a leader in the Indian branded generics market, for an up-front payment of $2.12 billion, plus $400 million annually for the next four years, giving Abbott the No. 1 position in the Indian pharmaceutical market.

21 May 2010

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

British Columbia is leading the way in vaccinations to protect children from serious disease. The province is the first in Canada to include Prevnar 13, the vaccine that provides the broadest coverage available against Streptococcus pneumoniae that may cause invasive pneumococcal disease, in the routine child immunization program.

21 May 2010

Dementia patients treated with neuroleptic drugs instead of anti-dementia medication: Study

Demented patients are often treated nonspecifically with psychoactive medications. Neuroleptic drugs are given even when they are not specifically indicated, as Tomislav Majic and his colleagues from the Charité Hospital, Berlin, show in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2010; 107[18]: 320-7).

21 May 2010

Medco: Big jump in kids' prescription drug use last year

Children's prescription drug use rose "several times faster" than adult use last year, "due in part to swine flu drugs and Type 2 diabetes medications, according to Medco Health Solutions Inc," The Associated Press reports. The "pharmacy benefits manager said a 5 percent increase in prescription drug use for children contributed to a 10.8 percent spending increase last year. In contrast, overall prescription drug use rose 1.3 percent, and drug spending climbed 3.7 percent. Medco released its annual drug trend report Wednesday" (Murphy, 5/19).

21 May 2010

EpiCept launches Ceplene in Germany

EpiCept Corporation today announced the commercial launch of Ceplene (R) (histamine dihydrochloride) in Germany. The launch is being conducted by Meda AB, as part of an exclusive commercialization agreement for Ceplene signed by the two companies in January 2010.

21 May 2010

WHA addresses counterfeit medicines

Discussions about combatting counterfeit medicines continued at the 63rd World Health Assembly (WHA) in Geneva on Wednesday, Agence France-Press reports

21 May 2010

Research and movement in future towards universal influenza virus vaccine

Researchers at Mt. Sinai School of Medicine have developed a novel influenza vaccine that could represent the next step towards a universal influenza vaccine eliminating the need for seasonal immunizations. They report their findings today in the inaugural issue of mBio-, the first online, open-access journal published by the American Society for Microbiology.

20 May 2010

Pharmaceutical News

Researchers test NicVAX vaccine to help people quit smoking, avoid relapses

Updates on Micromet's BiTE antibody development programs to be made at two medical conferences

Dr. Reddy's Laboratories launches tacrolimus capsules in the US market

Vitacost.com announces expansion of operations in North Carolina

IGF1 drug improves nerve cell communication in PMS mouse model

Common misconceptions about general anesthesia

Influenza antiviral drugs not hoarded during recent H1N1 flu season, says Prime Therapeutics

New data highlighting Pfizer's approach to cancer drug development to be presented at ASCO meeting

Sorrento Therapeutics receives STTR grant to develop antibody therapeutics to combat MRSA

Genentech to present new data for targeted cancer medicines at 46th ASCO

Americans divided over nation’s drug approval process

VIA-2291 can reduce inflammation in patients with atherosclerosis: Study

Salix announces additional intellectual property protection for rifaximin in treatment of IBS

Abbott to acquire Piramal's Healthcare Solutions business

British Columbia first in Canada to include Prevnar 13 in routine child immunization program

Dementia patients treated with neuroleptic drugs instead of anti-dementia medication: Study

Medco: Big jump in kids' prescription drug use last year

EpiCept launches Ceplene in Germany

WHA addresses counterfeit medicines

Research and movement in future towards universal influenza virus vaccine

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News